In summary, our results suggest that increased generation of melatonin-induced intracellular ROS in U87MG glioblastoma cells may be an effect of melatonin on the expression of TFAM and other mitochondrial transcription factors (TFB1M and TFB2M), leading to mitochondrial disruption. The gene discussed is TFAM; the disease is glioblastoma.